TBPH vs JNJ: Which Stock is Better?
Side-by-side comparison of Theravance Biopharma Inc and Johnson & Johnson in 2026
TBPH
Theravance Biopharma Inc
—
JNJ
Johnson & Johnson
$265.53
Key Metrics Comparison
| Metric | TBPH | JNJ | Winner |
|---|---|---|---|
| Market Cap | $861.45M | $375.37B | JNJ |
| P/E Ratio | 7.49 | 17.35 | TBPH |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze TBPH
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TBPH or JNJ a better investment?
Comparing TBPH and JNJ: Theravance Biopharma Inc has a market cap of $861.45M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TBPH and JNJ?
TBPH (Theravance Biopharma Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TBPH or JNJ?
Based on P/E ratios, TBPH trades at a lower multiple (7.5x vs 17.4x).
Which is growing faster: TBPH or JNJ?
Both TBPH and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: TBPH or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: TBPH or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $861.45M for TBPH.
Should I buy TBPH or JNJ in 2026?
Both TBPH and JNJ have investment merit. TBPH trades at $N/A while JNJ trades at $265.53. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TBPH and JNJ stock?
Key differences: Market Cap ($861.45M vs $375.37B), P/E Ratio (7.5x vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy TBPH or JNJ in 2026?
The choice between TBPH and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between TBPH and JNJ?
TBPH (Theravance Biopharma Inc) has a market cap of $861.45M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.